CME Group(US:CME) ZACKS·2025-10-15 15:02Core Viewpoint - CME Group is anticipated to report a year-over-year decline in earnings and revenues for the quarter ended September 2025, which could significantly influence its stock price depending on the actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on October 22, with a consensus estimate of $2.64 per share, reflecting a -1.5% change year-over-year. Revenues are projected to be $1.54 billion, down 2.7% from the previous year [3][2]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 1.15% lower, indicating a reassessment by analysts [4]. The Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a positive reading being a strong predictor of an earnings beat, especially when combined with a strong Zacks Rank [9][10]. Historical Performance - CME has beaten consensus EPS estimates in the last four quarters, with the most recent quarter showing a surprise of +1.72% [13][14]. Industry Comparison - In contrast, Nasdaq is expected to report earnings of $0.84 per share for the same quarter, indicating a +13.5% year-over-year change, with revenues expected to rise by 12.2% [18]. Nasdaq's consensus EPS estimate has been revised 1.8% higher, resulting in an Earnings ESP of +2.15%, suggesting a likely earnings beat [19].